Papers by Sergi Valero · AgingResearch.News

Journal of Alzheimer's Disease30 Sep
A single-center open-label, randomized, parallel-group controlled clinical trial on the long-term effect of the treatment with EGb 761 in blood markers of inflammation and neurodegeneration in patients with mild cognitive impairment: ACE-2020-EGb 761
Randomised trial in 100 peopleMild cognitive impairment
Paper
Frontiers in Aging Neuroscience20 Aug
Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism
Cohort study of 1,859 peopleAlzheimer's disease
Paper
The Journal of Prevention of Alzheimer's Disease13 Aug
Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract8 Jan
ApoE Genotyping and 12‐Month Longitudinal Tracking of p ‐Tau217 Using Fingerstick Collection in a Population‐Based Cohort
Study in peopleBiomarkers
Paper

AAIC 2025 Abstract25 Dec
Real‐World Experience With Plasma PTAU217 as a Screening Tool of Patients at Risk of Alzheimer's Disease in a Memory Clinic
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract24 Dec
Neurological and inflammatory biomarkers in CSF along the Alzheimer's Disease spectrum
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract23 Dec
Long‐Read Sequencing Reveals Ancestral intragenic APOE Haplotypes with Distinct Roles in Alzheimer’s Disease
Study in peoplePopulations
Paper